Artificial intelligence uncertainty quantification in radiotherapy applications - A scoping review

Abstract

Background/purpose: The use of artificial intelligence (AI) in radiotherapy (RT) is expanding rapidly. However, there exists a notable lack of clinician trust in AI models, underscoring the need for effective uncertainty quantification (UQ) methods. The purpose of this study was to scope existing literature related to UQ in RT, identify areas of improvement, and determine future directions.

Methods: We followed the PRISMA-ScR scoping review reporting guidelines. We utilized the population (human cancer patients), concept (utilization of AI UQ), context (radiotherapy applications) framework to structure our search and screening process. We conducted a systematic search spanning seven databases, supplemented by manual curation, up to January 2024. Our search yielded a total of 8980 articles for initial review. Manuscript screening and data extraction was performed in Covidence. Data extraction categories included general study characteristics, RT characteristics, AI characteristics, and UQ characteristics.

Results: We identified 56 articles published from 2015 to 2024. 10 domains of RT applications were represented; most studies evaluated auto-contouring (50 %), followed by image-synthesis (13 %), and multiple applications simultaneously (11 %). 12 disease sites were represented, with head and neck cancer being the most common disease site independent of application space (32 %). Imaging data was used in 91 % of studies, while only 13 % incorporated RT dose information. Most studies focused on failure detection as the main application of UQ (60 %), with Monte Carlo dropout being the most commonly implemented UQ method (32 %) followed by ensembling (16 %). 55 % of studies did not share code or datasets.

Conclusion: Our review revealed a lack of diversity in UQ for RT applications beyond auto-contouring. Moreover, we identified a clear need to study additional UQ methods, such as conformal prediction. Our results may incentivize the development of guidelines for reporting and implementation of UQ in RT.

Fig. 1.

General study characteristics. (A) Stacked barplot showing total number of publications per country by publication type. (B) Heatmap of the number of studies by continent where green indicates a low number of publications and blue indicates a high number of publications; continents where no studies were extracted from are represented in white. (C) Stacked barplot showing code and data availability over time. Each item in the barplots corresponds to one study. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Fig. 2.

Radiotherapy characteristics. (A) Stacked barplot showing cancer disease site per each radiotherapy application domain. “Other” category for cancer type included cervical, liver, esophageal, pancreatic, cardiac, breast, pelvic. “Other” category for radiotherapy application included nodal classification, tumor growth modeling, and image correction. (B) Stacked barplot showing additional data per each imaging modality represented. “Other” category for additional data included registration transforms, respiratory trace, K-space, fiducial, clinical data, target + clinical data, dose + clinical data, and dose + clinical data + target + probability map. Each item in the barplots correspond to one study.

Fig. 3.

Artificial intelligence characteristics. (A) Scatter plot showing number of training, validation, and testing patients used in studies. Only studies that explicitly reported patient-level sample sizes are included. The three studies with the highest sample sizes in each category are annotated. (B) Bar plot showing types of testing strategies used in studies. Each item in the barplot corresponds to one study.

Fig. 4.

Uncertainty quantification characteristics. (A) Tree map of uncertainty quantification applications represented in the studies. (B) Tree map of uncertainty quantification methods represented in the studies. (C) Tree map of uncertainty quantification metrics represented in the studies. Each item in the tree maps correspond to a reported item (could be multiple per study).